+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biopsy Guidance System Market - Global Forecast 2026-2032- Product Image
Biopsy Guidance System Market - Global Forecast 2026-2032- Product Image
New

Biopsy Guidance System Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 195 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5454872
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Biopsy guidance systems are redefining clinical workflows by improving lesion targeting accuracy, reducing patient trauma, and accelerating diagnostic procedures. Senior stakeholders are increasingly focused on the strategic integration of these platforms within evolving clinical, operational, and reimbursement environments.

Market Snapshot: Biopsy Guidance System Market Growth

The Biopsy Guidance System Market grew from USD 1.66 billion in 2025 to USD 1.79 billion in 2026. It is expected to continue growing at a CAGR of 7.62%, reaching USD 2.78 billion by 2032. This growth is driven by rapid technology advancements, expanded clinical applications, and increased demand for value-based care solutions.

Scope & Segmentation of the Biopsy Guidance System Market

The global market encompasses a broad range of technology types, clinical applications, and user profiles. Segmentation clarifies how device selection is influenced by diverse clinical needs, technological platforms, and care environments:

  • Imaging Modalities: Computed tomography, magnetic resonance imaging, stereotactic guidance, ultrasound (including 2D, 3D, and Doppler), and X-ray systems.
  • Clinical Applications: Breast, kidney, liver, lung, prostate, and thyroid procedures, each with distinct diagnostic and operational requirements.
  • End Users: Ambulatory surgical centers, diagnostic imaging centers, hospitals (both private and public), and outpatient clinics.
  • Biopsy Types: Core needle biopsies (further differentiated by spring-loaded and vacuum-assisted methods) and fine needle aspiration.
  • Guidance Modalities: Manual systems (emphasizing portability and lower cost) and robotic-assisted solutions (prioritizing precision and integration with advanced imaging).
  • Geographic Regions: Americas, Europe, Middle East and Africa, and Asia Pacific, each with unique regulatory frameworks, adoption drivers, and procurement models.

Key Takeaways for Senior Decision-Makers

  • Adoption of biopsy guidance systems enhances care pathways by supporting precise lesion localization and reducing the frequency of repeat procedures, which aligns with institutional objectives for clinical throughput and quality.
  • Recent technology convergence—including high-resolution imaging, advanced software intelligence, and robotic assistance—reduces learning curves and improves procedure reproducibility across settings.
  • Procurement teams are shifting toward total cost of ownership considerations, as decision-makers evaluate device interoperability, supply chain resilience, and the ability to integrate with electronic health records and imaging platforms.
  • Collaborations between manufacturers and academic centers are increasingly vital in generating clinical evidence that supports broader adoption and guideline alignment, impacting reimbursement decisions.
  • Service and maintenance models, standardized remote diagnostics, and modular product architectures support long-term system performance with reduced operational risk.
  • Segment-specific requirements demand flexible product portfolios, enabling tailored solutions for high-acuity centers as well as decentralized care environments, particularly in regions prioritizing scalability and affordability.

Tariff Impact on Biopsy Guidance System Market

United States tariff measures implemented in 2025 have heightened attention to sourcing strategies and operational cost control in the biopsy guidance sector. Manufacturers are shifting toward diversified vendor networks, with an emphasis on localization and modular engineering to manage tariff exposure without compromising device capability. Healthcare providers and procurement leaders are closely scrutinizing component origin, total cost of ownership, and after-sales service responsiveness. These adjustments are preserving continuity of care while reshaping competitive dynamics and supply chain strategies across the value chain.

Methodology & Data Sources

This research applies a mixed-methods framework combining firsthand interviews with key clinical, procurement, and technical stakeholders and comprehensive secondary validation from peer-reviewed literature, regulatory sources, and industry documentation. Triangulation and scenario analysis support robustness, while documentation of inclusion criteria and limitations ensures transparency.

Why This Report Matters

  • Supports strategic procurement and investment decisions by aligning market insights with evolving regulatory, clinical, and operational priorities.
  • Identifies actionable product development and commercialization strategies, enabling stakeholders to address regional and technological preferences.
  • Reveals risk factors and best practices around supply chain management, interoperability, and clinical evidence generation within the sector.

Conclusion

The future of the biopsy guidance system market will be shaped by continued convergence of technology, robust clinical validation, and strategic collaboration across stakeholders. Aligning organizational strategy with these trends positions decision-makers to advance safe, efficient, and scalable diagnostic care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Biopsy Guidance System Market, by Imaging Technology
8.1. Computed Tomography
8.2. Magnetic Resonance Imaging
8.3. Stereotactic
8.4. Ultrasound
8.4.1. 2D Ultrasound
8.4.2. 3D Ultrasound
8.4.3. Doppler Ultrasound
8.5. X Ray
9. Biopsy Guidance System Market, by Biopsy Type
9.1. Core Needle Biopsy
9.1.1. Spring Loaded
9.1.2. Vacuum Assisted
9.2. Fine Needle Aspiration
10. Biopsy Guidance System Market, by Guidance System
10.1. Manual
10.2. Robotic Assisted
11. Biopsy Guidance System Market, by Application
11.1. Breast
11.2. Kidney
11.3. Liver
11.4. Lung
11.5. Prostate
11.6. Thyroid
12. Biopsy Guidance System Market, by End User
12.1. Ambulatory Surgical Centers
12.2. Diagnostic Imaging Centers
12.3. Hospitals
12.3.1. Private Hospitals
12.3.2. Public Hospitals
12.4. Outpatient Clinics
13. Biopsy Guidance System Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Biopsy Guidance System Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Biopsy Guidance System Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Biopsy Guidance System Market
17. China Biopsy Guidance System Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Argon Medical Devices, Inc.
18.6. B. Braun Melsungen AG
18.7. Becton, Dickinson and Company
18.8. Boston Scientific Corporation
18.9. Canon Medical Systems Corporation
18.10. Cardinal Health, Inc.
18.11. Cook Medical, Inc.
18.12. Fujifilm Holdings Corporation
18.13. GE HealthCare Technologies Inc.
18.14. Hologic, Inc.
18.15. Koninklijke Philips N.V.
18.16. Medtronic plc
18.17. Olympus Corporation
18.18. Siemens Healthineers AG
18.19. Stryker Corporation
List of Figures
FIGURE 1. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BIOPSY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY GUIDANCE SYSTEM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STEREOTACTIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STEREOTACTIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STEREOTACTIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY 2D ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY 2D ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY 2D ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY 3D ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY 3D ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY 3D ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY DOPPLER ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY DOPPLER ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY DOPPLER ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY X RAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY X RAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY X RAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BIOPSY TYPE, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY CORE NEEDLE BIOPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY CORE NEEDLE BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY CORE NEEDLE BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY CORE NEEDLE BIOPSY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY SPRING LOADED, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY SPRING LOADED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY SPRING LOADED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY VACUUM ASSISTED, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY VACUUM ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY VACUUM ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ROBOTIC ASSISTED, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ROBOTIC ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ROBOTIC ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BREAST, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BREAST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BREAST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY KIDNEY, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY KIDNEY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY KIDNEY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY LIVER, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY LIVER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY LIVER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY LUNG, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY LUNG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY LUNG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PROSTATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PROSTATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PROSTATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY THYROID, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY THYROID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY THYROID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY OUTPATIENT CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY OUTPATIENT CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BIOPSY TYPE, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY CORE NEEDLE BIOPSY, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 97. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BIOPSY TYPE, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY CORE NEEDLE BIOPSY, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BIOPSY TYPE, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY CORE NEEDLE BIOPSY, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BIOPSY TYPE, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY CORE NEEDLE BIOPSY, 2018-2032 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2032 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 125. EUROPE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. EUROPE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 127. EUROPE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 128. EUROPE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BIOPSY TYPE, 2018-2032 (USD MILLION)
TABLE 129. EUROPE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY CORE NEEDLE BIOPSY, 2018-2032 (USD MILLION)
TABLE 130. EUROPE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2032 (USD MILLION)
TABLE 131. EUROPE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 132. EUROPE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 133. EUROPE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BIOPSY TYPE, 2018-2032 (USD MILLION)
TABLE 138. MIDDLE EAST BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY CORE NEEDLE BIOPSY, 2018-2032 (USD MILLION)
TABLE 139. MIDDLE EAST BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 141. MIDDLE EAST BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. MIDDLE EAST BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 143. AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 145. AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 146. AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BIOPSY TYPE, 2018-2032 (USD MILLION)
TABLE 147. AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY CORE NEEDLE BIOPSY, 2018-2032 (USD MILLION)
TABLE 148. AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2032 (USD MILLION)
TABLE 149. AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 150. AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 151. AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BIOPSY TYPE, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY CORE NEEDLE BIOPSY, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. ASEAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. ASEAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 164. ASEAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 165. ASEAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BIOPSY TYPE, 2018-2032 (USD MILLION)
TABLE 166. ASEAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY CORE NEEDLE BIOPSY, 2018-2032 (USD MILLION)
TABLE 167. ASEAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2032 (USD MILLION)
TABLE 168. ASEAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 169. ASEAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. ASEAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 171. GCC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. GCC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 173. GCC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 174. GCC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BIOPSY TYPE, 2018-2032 (USD MILLION)
TABLE 175. GCC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY CORE NEEDLE BIOPSY, 2018-2032 (USD MILLION)
TABLE 176. GCC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2032 (USD MILLION)
TABLE 177. GCC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 178. GCC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 179. GCC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BIOPSY TYPE, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY CORE NEEDLE BIOPSY, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 189. BRICS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. BRICS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 191. BRICS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 192. BRICS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BIOPSY TYPE, 2018-2032 (USD MILLION)
TABLE 193. BRICS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY CORE NEEDLE BIOPSY, 2018-2032 (USD MILLION)
TABLE 194. BRICS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2032 (USD MILLION)
TABLE 195. BRICS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 196. BRICS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 197. BRICS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 198. G7 BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. G7 BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 200. G7 BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 201. G7 BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BIOPSY TYPE, 2018-2032 (USD MILLION)
TABLE 202. G7 BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY CORE NEEDLE BIOPSY, 2018-2032 (USD MILLION)
TABLE 203. G7 BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2032 (USD MILLION)
TABLE 204. G7 BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 205. G7 BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 206. G7 BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 207. NATO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. NATO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 209. NATO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 210. NATO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BIOPSY TYPE, 2018-2032 (USD MILLION)
TABLE 211. NATO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY CORE NEEDLE BIOPSY, 2018-2032 (USD MILLION)
TABLE 212. NATO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2032 (USD MILLION)
TABLE 213. NATO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 214. NATO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 215. NATO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 216. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 218. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 219. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 220. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BIOPSY TYPE, 2018-2032 (USD MILLION)
TABLE 221. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY CORE NEEDLE BIOPSY, 2018-2032 (USD MILLION)
TABLE 222. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2032 (USD MILLION)
TABLE 223. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 224. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 225. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 226. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 227. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 228. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 229. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BIOPSY TYPE, 2018-2032 (USD MILLION)
TABLE 230. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY CORE NEEDLE BIOPSY, 2018-2032 (USD MILLION)
TABLE 231. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2032 (USD MILLION)
TABLE 232. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 233. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 234. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Biopsy Guidance System market report include:
  • Argon Medical Devices, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Cardinal Health, Inc.
  • Cook Medical, Inc.
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • Medtronic plc
  • Olympus Corporation
  • Siemens Healthineers AG
  • Stryker Corporation

Table Information

Report AttributeDetails
No. of Pages195
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.79 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.78 Billion
Compound Annual Growth Rate7.6%
Regions CoveredGlobal
No. of Companies Mentioned16

Related Topics

Related Reports

Breast Biopsy Device Market - Global Forecast 2026-2032 - Product Image

Breast Biopsy Device Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Breast Biopsy Market - Global Forecast 2026-2032 - Product Image

Breast Biopsy Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Biopsy Guidance Systems - Global Strategic Business Report - Product Image

Biopsy Guidance Systems - Global Strategic Business Report

  • Report
  • 273 Pages
  • Global
From
Biopsy Devices Market Report by Procedure Type, Product, Application, Guidance Technique, End User, and Region 2025-2033 - Product Image

Biopsy Devices Market Report by Procedure Type, Product, Application, Guidance Technique, End User, and Region 2025-2033

  • Report
  • 141 Pages
  • Global
From
Soft Tissue Biopsy Pinhead Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Soft Tissue Biopsy Pinhead Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.